Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
2.26 x 10 2.59 x 3
Post-market by (Cboe BZX)
2.41 -0.11 (-4.37%) 04/25/25 [NASDAQ]
2.26 x 10 2.59 x 3
Post-market 2.30 -0.11 (-4.56%) 19:42 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Zynex Inc 9655 MAROON CIRCLE ENGLEWOOD CO 80112 USA

www.zynex.com Employees: 1,000 P: 303-703-4906 F: 855-845-5941

Sector:

Medical

Description:

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 76,172
Enterprise Value, $K 36,542
Shares Outstanding, K 30,227
Annual Sales, $ 192,350 K
Annual Net Income, $ 2,990 K
Last Quarter Sales, $ 45,970 K
Last Quarter Net Income, $ -620 K
EBIT, $ 5,990 K
EBITDA, $ 10,770 K
60-Month Beta 1.09
% of Insider Shareholders 49.28%
% of Institutional Shareholders 29.68%
Float, K 15,331
% Float 50.72%
Short Volume Ratio 0.29

Growth:

1-Year Return -77.97%
3-Year Return -62.17%
5-Year Return -83.81%
5-Year Revenue Growth 323.03%
5-Year Earnings Growth -64.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 03/11/25
Next Earnings Date 11/10/16
Earnings Per Share ttm 0.09
EPS Growth vs. Prev Qtr -128.57%
EPS Growth vs. Prev Year -150.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.150 on 06/17/14
Dividend Payable Date 06/27/14
Dividend Payout Ratio 0.00%
Most Recent Split 11-10 on 01/05/22

ZYXI Ratios

Ratio
Price/Earnings ttm 27.11
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 8.72%
Return-on-Assets % 2.41%
Profit Margin % 1.55%
Debt/Equity 0.00
Price/Sales 0.38
Price/Cash Flow 9.99
Price/Book 2.18
Book Value/Share 1.12
Interest Coverage 2.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective